Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chaoju Eye Care HoldingsHKSE:02219 +4.66%93 Current Ratio is 4.37 as of Dec. 2025, which is 7% below its 10-year median of 4.70. GuruFocus rates HKSE:02219 with a GF Score™ of 93/100 and a GF Value™ of HK$3.47 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Chaoju Eye Care Holdings ranks better than 86.88% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Chaoju Eye Care Holdings's current ratio for the quarter that ended in Dec. 2025 was 4.37.
Chaoju Eye Care Holdings has a current ratio of 4.37. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Chaoju Eye Care Holdings's Current Ratio or its related term are showing as below:
HKSE:02219'
s Current Ratio Range Over the Past 10 Years
Min: 1.17 Med: 4.7 Max: 8.63
Current: 4.37
During the past 8 years, Chaoju Eye Care Holdings's highest Current Ratio was 8.63. The lowest was 1.17. And the median was 4.70.
HKSE:02219's Current Ratio is ranked better than 86.88% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.42
vs HKSE:02219: 4.37
Chaoju Eye Care Holdings (HKSE:02219) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Chaoju Eye Care Holdings Current Ratio Related Terms
Chaoju Eye Care Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02219 vs HCA, THC, EHC: Current Ratio Comparison
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings (HKSE:02219) has a Current Ratio of 4.37 as of Dec. 2025. This is near median its historical median of 4.70. Over the past decade, Chaoju Eye Care Holdings' Current Ratio has ranged from 1.17 to 8.63. According to the industry distribution chart, Chaoju Eye Care Holdings ranks #90 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 13.1%.
Is Chaoju Eye Care Holdings' Current Ratio too high?
Chaoju Eye Care Holdings' current Current Ratio of 4.37 is near median its 10-year median of 4.70. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 8.63. The Healthcare Providers & Services industry median Current Ratio is 1.42. Chaoju Eye Care Holdings' value of 4.37 is 207.7% above this industry median. Based on the distribution chart, Chaoju Eye Care Holdings ranks #90 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chaoju Eye Care Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chaoju Eye Care Holdings ranks #90 out of 686 companies for Current Ratio. This places Chaoju Eye Care Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.42. Chaoju Eye Care Holdings' value of 4.37 is 207.7% above this benchmark. Historically, Chaoju Eye Care Holdings' own Current Ratio has ranged from 1.17 to 8.63 over the past decade. While the company's 10-year median is 4.70 vs. the industry median of 1.42, Chaoju Eye Care Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.42, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chaoju Eye Care Holdings's current Current Ratio of 4.37 is 207.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chaoju Eye Care Holdings's current Current Ratio is 4.37, which is near median its own 10-year median of 4.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.47, compared to a current price of HK$2.47 — trading 28.8% below its estimated fair value. The current Current Ratio is 4.37, which is near median its 10-year median of 4.70 and 207.7% above the Healthcare Providers & Services industry median of 1.42. Chaoju Eye Care Holdings' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current Current Ratio is 4.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.47 is trading 28.8% below its estimated GF Value™ of HK$3.47.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
Current Ratio: 4.37 (near median its 10-year median of 4.70)
GF Value™: HK$3.47 vs. price of HK$2.47 (28.8% below fair value)
Industry Position: 207.7% above the Healthcare Providers & Services median (#90 of 686)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
93GF Score
Get the complete analysis for HKSE:02219
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
